Related Experiment Video
Updated: Aug 7, 2026

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro
Published on: March 18, 2014
Arsenite induces delayed mutagenesis and transformation in human osteosarcoma cells at extremely low concentrations
Kanae Mure1, Ahmed N Uddin, Laura C Lopez
1New York University School of Medicine, Nelson Institute of Environmental Medicine, Tuxedo, New York 10987, USA.
Abstract:
Arsenite is a human multisite carcinogen, but its mechanism of action is not known. We recently found that extremely low concentrations (=0.1 microM) of arsenite transform human osteosarcoma TE85 (HOS) cells to anchorage-independence. In contrast to other carcinogens which transform these cells within days of exposure, almost 8 weeks of arsenite exposure are required for transformation. We decided to reexamine the question of arsenite mutagenicity using chronic exposure in a spontaneous mutagenesis assay we previously developed. Arsenite was able to cause a delayed increase in mutagenesis at extremely low concentrations (=0.1 microM) in a dose-dependent manner. The increase in mutant frequency occurred after almost 20 generations of growth in arsenite. Transformation required more than 30 generations of continuous exposure. We also found that arsenite induced gene amplification of the dihydrofolate reductase (DHFR) gene in a dose-dependent manner. Since HOS cells are able to methylate arsenite at a very low rate, it was possible that active metabolites such as monomethylarsonous acid (MMA(III)) contributed to the delayed mutagenesis and transformation in these cells. However, when the assay was repeated with MMA(III), we found no significant increase in mutagenesis or transformation, suggesting that arsenite-induced delayed mutagenesis and transformation are not caused by arsenite's metabolites, but by arsenite itself. Our results suggest that long-term exposure to low concentrations of arsenite may affect signaling pathways that result in a progressive genomic instability.
Insights
Long-term exposure to low concentrations of arsenite causes delayed mutagenesis and cell transformation. Arsenite itself, not its metabolites, drives these effects, suggesting progressive genomic instability.
Area of Science:
- Environmental Health
- Toxicology
- Carcinogenesis
Background:
- Arsenite is a known human carcinogen, but its precise mechanism of action remains unclear.
- Previous research indicated arsenite transforms human osteosarcoma cells (HOS) to anchorage-independence after prolonged exposure (8 weeks).
Purpose of the Study:
- To investigate the mutagenic and transformative effects of chronic, low-dose arsenite exposure.
- To determine if arsenite metabolites contribute to its carcinogenic effects.
Main Methods:
- Utilized a spontaneous mutagenesis assay with chronic exposure of HOS cells to arsenite.
- Assessed mutagenesis and transformation rates over multiple cell generations.
- Investigated the role of monomethylarsonous acid (MMA(III)), a potential arsenite metabolite.
Main Results:
- Arsenite induced a delayed, dose-dependent increase in mutagenesis after approximately 20 generations.
- Cell transformation required over 30 generations of continuous arsenite exposure.
- Arsenite, not MMA(III), was responsible for the observed delayed mutagenesis and transformation, and induced dose-dependent dihydrofolate reductase (DHFR) gene amplification.
Conclusions:
- Long-term, low-level arsenite exposure can lead to delayed mutagenesis and transformation.
- Arsenite itself, rather than its metabolites, appears to be the primary driver of these effects.
- These findings suggest arsenite may promote progressive genomic instability through signaling pathway alterations.
Related Concept Videos
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Mutagenicity and Carcinogenicity
Spontaneous and Induced Mutations

